Finance

Lists
BMEA:NASDAQ
Biomea Fusion Inc
US$ १.२८
०.००%
(०.००) 1D
US$ १.२८
+०.२०% (+०.००२६)
After hours
Closed: अगस्ट १३, १६:००:०१ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BMEA...
Open
US$ १.२७
High
US$ १.३२
Low
US$ १.२७
Mkt. cap
९.२८ करोड
Avg. vol.
६.६४ लाख
Volume
३.८७ लाख
52-wk high
US$ २.९९
52-wk low
US$ ०.८७
EPS
-US$ ०.५०
Beta
-०.२८
Shares outstanding
७.२५ करोड
No. of employees
३७
Open
US$ १.२७
High
US$ १.३२
Low
US$ १.२७
Mkt. cap
९.२८ करोड
Avg. vol.
६.६४ लाख
Volume
३.८७ लाख
52-wk high
US$ २.९९
52-wk low
US$ ०.८७
EPS
-US$ ०.५०
Beta
-०.२८
Shares outstanding
७.२५ करोड
No. of employees
३७
News stories
From web sources and news partners
Investing.com
Investing.com
·
१० घण्टा पहिले
Biomea Fusion doses first patient in icovamenib-semaglutide study
About Biomea Fusion Inc
CEO-
Employees३७
Founded२०१७
HeadquartersSan Carlos, क्यालिफोर्निया, संयुक्त राज्य अमेरिका
Sector-
Websitebiomeafusion.com
Analyst ratings
Based on 5 analysts giving stock ratings to BMEA in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for BMEA in the last 3 months.
Highest
Current US$ १.२८
US$ ९.०० (+६०३.१२%)
Average
US$ ६.८० (+४३१.२५%)
Lowest
US$ ४.०० (+२१२.५०%)
Analyst
Recommendation
Action
Price target
Projected
Date
Joseph Pantginis
H.C. Wainwright
Buy
Maintained
US$ ४.००
+२१२.५%
08/13/2026
Yigal Nochomovitz
Citi
Buy
Reiterated
US$ ७.००
+४४६.९%
08/10/2026
Jonathan Wolleben
Citizens JMP
Buy
Maintained
US$ ७.००
+४४६.९%
08/06/2026
Matthew Biegler
Oppenheimer
Buy
Reiterated
US$ ९.००
+६०३.१%
08/06/2026
Edward Tenthoff
Piper Sandler
Buy
Reiterated
US$ ७.००
+४४६.९%
08/06/2026
Anupam Rama
J.P. Morgan
Sell
Maintained
-
-
03/24/2026
Last report
२०२६ अगस्ट ५
Fiscal period
Q2 2026
EPS / Est. (USD)
-US$ ०.१२ / -US$ ०.२३
+४८.०७%beat
Revenue / Est. (USD)
- / ०.००
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
१.४४ करोड
८१.१५ लाख
९१.२० लाख
९१.४२ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
४१.९९ लाख
३६.०४ लाख
३६.५४ लाख
३६.२४ लाख
Operating expense
१.८६ करोड
१.१७ करोड
१.२८ करोड
१.२८ करोड
Total operating expenses
१.८६ करोड
१.१७ करोड
१.२८ करोड
१.२८ करोड
Operating income
-१.८६ करोड
-१.१७ करोड
-१.२८ करोड
-१.२८ करोड
Other non operating income
-
१.९९ करोड
-५.८१ लाख
४१.१९ लाख
EBT including unusual items
-१.६४ करोड
४६.१२ लाख
-१.२४ करोड
-८३.२८ लाख
EBT excluding unusual items
-१.४२ करोड
४६.१२ लाख
-१.२९ करोड
-८३.२८ लाख
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-१.६४ करोड
४६.१२ लाख
-१.२४ करोड
-८३.२८ लाख
Net profit margin
-
-
-
-
Earnings per share
-०.२४
-०.१२
-०.१७
-०.१७
Interest and investment income
४३.९८ लाख
-
४.३० लाख
३.१९ लाख
Interest expense
-
-३५.२६ लाख
-
-
Net interest expenses
४३.९८ लाख
-३५.२६ लाख
४.३० लाख
३.१९ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-१.८२ करोड
-१.१७ करोड
-१.२७ करोड
-१.२७ करोड
Gain or loss from assets sale
-
-
-५.१० लाख
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू